A subpopulation of CD146

Animals Humans Inflammasomes / metabolism NLR Family, Pyrin Domain-Containing 3 Protein / metabolism CD146 Antigen / metabolism Neoplasms Macrophages Tumor Microenvironment
CD146 Inflammasome TMEM176B Tumor immunotherapy Tumor-associated macrophages

Journal

Cellular & molecular immunology
ISSN: 2042-0226
Titre abrégé: Cell Mol Immunol
Pays: China
ID NLM: 101242872

Informations de publication

Date de publication:
08 2023
Historique:
received: 14 09 2022
accepted: 22 05 2023
medline: 1 8 2023
pubmed: 13 6 2023
entrez: 12 6 2023
Statut: ppublish

Résumé

As one of the main tumor-infiltrating immune cell types, tumor-associated macrophages (TAMs) determine the efficacy of immunotherapy. However, limited knowledge about their phenotypically and functionally heterogeneous nature restricts their application in tumor immunotherapy. In this study, we identified a subpopulation of CD146

Identifiants

DOI: 10.1038/s41423-023-01047-4 PMID: 37308559 PMC: PMC10387481
pubmed: 37308559
doi: 10.1038/s41423-023-01047-4
pii: 10.1038/s41423-023-01047-4
pmc: PMC10387481
doi:

Substances chimiques

Inflammasomes 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
CD146 Antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

908-923

Informations de copyright

© 2023. The Author(s).

Références

Oncoimmunology. 2015 Jan 22;4(4):e998529
pubmed: 26137415
Nat Immunol. 2022 Aug;23(8):1148-1156
pubmed: 35879449
Front Immunol. 2020 Dec 03;11:583084
pubmed: 33365025
Nat Med. 2015 Aug;21(8):938-945
pubmed: 26193342
Chem Rev. 2016 Aug 24;116(16):9001-90
pubmed: 27428515
Cancer Discov. 2018 Sep;8(9):1069-1086
pubmed: 30115704
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Cancers (Basel). 2021 Apr 18;13(8):
pubmed: 33919517
Blood. 2003 Jul 1;102(1):184-91
pubmed: 12609848
Mol Immunol. 2020 Jan;117:201-215
pubmed: 31835202
Cell. 2016 May 5;165(4):792-800
pubmed: 27153493
Cancer Cell. 2015 Apr 13;27(4):450-61
pubmed: 25858804
Sci China Life Sci. 2022 Jun;65(6):1157-1170
pubmed: 34729700
Nature. 2016 Nov 17;539(7629):443-447
pubmed: 27828943
J Immunol Res. 2018 Oct 17;2018:4625472
pubmed: 30417020
Hybridoma (Larchmt). 2008 Oct;27(5):345-52
pubmed: 18847347
Nat Rev Clin Oncol. 2017 Jul;14(7):399-416
pubmed: 28117416
J Neurotrauma. 2020 Feb 1;37(3):528-533
pubmed: 31354034
J Clin Periodontol. 2020 Apr;47(4):451-460
pubmed: 31976565
Cell Res. 2017 Mar;27(3):352-372
pubmed: 28084332
Cancer Cell. 2019 May 13;35(5):767-781.e6
pubmed: 31085177
Mol Cancer. 2020 Sep 24;19(1):145
pubmed: 32972405
Signal Transduct Target Ther. 2020 Aug 11;5(1):148
pubmed: 32782280
Signal Transduct Target Ther. 2021 Feb 23;6(1):75
pubmed: 33619259
Sci Rep. 2013;3:1687
pubmed: 23595028
J Clin Invest. 2021 Nov 1;131(21):
pubmed: 34491908
Am J Pathol. 2013 Mar;182(3):819-27
pubmed: 23256918
Am J Transplant. 2014 May;14(5):1021-1031
pubmed: 24731243
Nat Rev Immunol. 2020 Nov;20(11):651-668
pubmed: 32433532
Mol Cancer. 2019 Dec 5;18(1):177
pubmed: 31805946
Int Immunopharmacol. 2018 Sep;62:29-39
pubmed: 29990692
Adv Sci (Weinh). 2022 May;9(13):e2103719
pubmed: 35258174
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Cell Mol Immunol. 2021 Oct;18(10):2443-2454
pubmed: 33203936
Trends Immunol. 2019 Apr;40(4):310-327
pubmed: 30890304
J Cell Biochem. 2018 Nov;119(11):9419-9432
pubmed: 30015355
Nat Rev Drug Discov. 2018 Sep;17(9):688
pubmed: 30116046
Ann N Y Acad Sci. 2021 Sep;1499(1):18-41
pubmed: 32445205
Mol Cancer. 2018 Nov 17;17(1):158
pubmed: 30447690
Cancer Res. 2016 Feb 1;76(3):513-6
pubmed: 26772756
Curr Opin Microbiol. 2023 Jun;73:102285
pubmed: 36857844
Blood. 2012 Sep 13;120(11):2330-9
pubmed: 22718841

Auteurs

Lin Jing (L)

Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

Yunhe An (Y)

Institute of Analysis and Testing, Beijing Academy of Science and Technology (Beijing Center for Physical and Chemical Analysis), No. 7 Fengxian Middle Street, Haidian District, Beijing, 100094, China.

Tanxi Cai (T)

Sino-Danish College, University of Chinese Academy of Sciences, Beijing, 100049, China.
Laboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

Jianquan Xiang (J)

Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.

Baoming Li (B)

Institute of Analysis and Testing, Beijing Academy of Science and Technology (Beijing Center for Physical and Chemical Analysis), No. 7 Fengxian Middle Street, Haidian District, Beijing, 100094, China.

Jiang Guo (J)

Department of Interventional Oncology, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, Beijing, 100015, China.

Xinran Ma (X)

Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.

Ling Wei (L)

Institute of Analysis and Testing, Beijing Academy of Science and Technology (Beijing Center for Physical and Chemical Analysis), No. 7 Fengxian Middle Street, Haidian District, Beijing, 100094, China.

Yanjie Tian (Y)

Institute of Analysis and Testing, Beijing Academy of Science and Technology (Beijing Center for Physical and Chemical Analysis), No. 7 Fengxian Middle Street, Haidian District, Beijing, 100094, China.

Xiaoyan Cheng (X)

Institute of Analysis and Testing, Beijing Academy of Science and Technology (Beijing Center for Physical and Chemical Analysis), No. 7 Fengxian Middle Street, Haidian District, Beijing, 100094, China.

Xuehui Chen (X)

Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

Zheng Liu (Z)

Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

Jing Feng (J)

Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

Fuquan Yang (F)

Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. fqyang@ibp.ac.cn.
Laboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. fqyang@ibp.ac.cn.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China. fqyang@ibp.ac.cn.

Xiyun Yan (X)

Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. yanxy@ibp.ac.cn.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China. yanxy@ibp.ac.cn.
Joint Laboratory of Nanozymes in Zhengzhou University, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China. yanxy@ibp.ac.cn.
ORCID: 0000-0002-7290-352X

Hongxia Duan (H)

Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. cherryshoen@ibp.ac.cn.
ORCID: 0000-0003-3995-1228

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › A subpopulation of CD146
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A subpopulation of CD146
questionsmedicales.fr › Structures macromoléculaires › Complexes multiprotéiques › Inflammasomes › A subpopulation of CD146
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Protéines NLR › Protéine-3 de la famille des NLR contenant un domaine pyrine › A subpopulation of CD146
questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes de surface › Molécules d'adhérence cellulaire › Antigènes CD146 › A subpopulation of CD146
questionsmedicales.fr › Tumeurs › A subpopulation of CD146
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Phagocytes › Macrophages › A subpopulation of CD146
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Microenvironnement cellulaire › Microenvironnement tumoral › A subpopulation of CD146